Skip to main content
. 2019 Apr 23;8:F1000 Faculty Rev-533. [Version 1] doi: 10.12688/f1000research.17296.1

Figure 2. Denosumab significantly suppresses the bone erosion score but has no effect on the joint-space narrowing score determined by modified Sharp scores.

Figure 2.

( a) Modified Sharp erosion score. ( b) Modified Sharp joint-space narrowing score. CI, confidence interval; Q2M, every 2 months; Q3M, every 3 months; Q6M, every 6 months. Modified from a figure in an article by Takeuchi et al. 30.